Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 75

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 75
---
 the criteria for assets held for sale during the fourth quarter of 2024 were combined with other disposal group assets and presented as a separate line item "Assets Held For Sale" in our consolidated balance sheets (See Note 4:Assets Held For Sale and Disposal of Business).

27

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

Note 14:      Property, Plant and Equipment

Property, plant and equipment consists of the following (in thousands): As of September 30, 2025December 31, 2024Machinery and equipment(1)$427,864 $400,861 Land, building and building improvements(1)179,894 177,089 Molds108,026 96,318 Computer equipment and software(1)114,191 122,208 Furniture and fixtures(1)26,589 27,871 Instruments placed with customers(2)145,251 124,290 Construction in progress(1)89,774 87,006 Total property, plant and equipment, cost(1)1,091,589 1,035,643 Accumulated depreciation(1)(635,622)(592,897)Property, plant and equipment, net(1)$455,967 $442,746 ______________________________ (1)      As of December 31, 2024, certain property, plant and equipment category account balances that are part of a disposal group that met the criteria for assets held for sale during the fourth quarter of 2024 were combined with other disposal group assets and presented as a separate line item "Assets held For Sale" in our consolidated balance sheets. (2)    Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.Depreciation expense was $17.7 million and $51.5 million for the three and nine months ended September 30, 2025, respectively, as compared to $21.4 million and $66.0 million for the three and nine months ended September 30, 2024, respectively. Depreciation expense included in costs of goods sold was $16.0 million and $46.2 million, for the three and nine months ended September 30, 2025, respectively, as compared to $18.5